Opcenter_Execution_Pharma

What’s new in Opcenter Execution Pharma version 2205

Simplifying the Process Instruction program rollout We are excited to announce that the latest version Opcenter™ Execution Pharma v. 2205…

Medical Devices and Diagnostics

What’s new in Opcenter EX MDD 8.8

Delivering an enhanced RESTful API for improved productivity, efficiency and quality We are excited to announce that the latest version…

Medical Devices and Diagnostics

What’s new in Opcenter Execution Medical Device and Diagnostics 8.7

Supporting greater collaboration and improving operational efficiency We are excited to announce that the latest version of Opcenter Execution Medical…

What’s new in Opcenter Execution Pharma version 6.2.4

Providing a paperless solution for the life sciences/pharma industries! We are excited to announce that the latest version Opcenter™ Execution…

The impact of new European Medical Device regulations

The New Regulation (EU) 2017/745 for medical devices (MDRs), which went into effect on May 26, 2021, is a major update to the regulatory framework in the European Union (EU).

Ask the Expert: Leveraging the Digital Infrastructure to Accelerate Growth

Today’s disruptive market scenarios, the unknown consequences of COVID-19, increasingly sophisticated personalized, and the new FDA and EU Regulatory implications…

Achieving Operational Excellence through Smart Manufacturing in Medical Devices

The COVID-19 pandemic has disrupted global supply chains on a monumental scale, rushing all MD&D manufacturers to quickly re-adapt and respond to new challenging market scenarios.

Opcenter Execution Medical Device and Diagnostics 8.6 has been released!

Delivering a new RESTful API, an advanced framework and improved configurability We are excited to announce that the latest version…

Two images of Terumo workers using Siemen's Opcenter to manage manufacturing and eDHR processes.

Opcenter helps medical device manufacturer reduce material release from days to minutes

Terumo Americas is a global leader in medical device industry manufacturing life-supporting and sustaining Class III devices across four divisions over the last 50 years, including interventional systems, injection and infusion therapy devices and drug delivery devices.